Tuesday 19 October 2021 -  9:00 to 13:30

The DG-GT would like to invite you to join their pre-conference morning, 

JOIN HERE from 8.30 on Tuesday 19 October

09:00 09:15 Opening Toni Cathomen DG-GT President Welcome to the DG-GT morning

Session 1 - Session 2 - Cell Therapy
CHAIR: Axel Schambach

09:15 09:30 DG-GT01 Marcel Rommel Paul Ehrlich-Institute, Langen Targeting Therapeutic Proteins to Alpha Granules for Platelet-mediated Transport and Delivery
09:30 09:45 DG-GT02 Claudio Rodriguez-Gonzalez Hannover Medical School iPSC-derived macrophages from Cystic Fibrosis patients for infection models and drug screening platforms.
09:45 10:30 Keynote Tobias Rothoeft Klinikum Bochum Junctional Epidermolysis Bullosa: The Bochum - Modena Experience
10:30 10:45 BREAK
Session 2 - Cancer Gene Therapy
CHAIR: Claudio Mussolino
10:45 11:00 DG-GT03 Lea Krutzke Ulm University Chorioallantoic Membrane tumour model for evaluating oncolytic viruses
11:00 11:15 DG-GT04 Naphang Ho Paul Ehrlich-Institute, Langen In vivo CAR T cell generation in humanized NSG-SGM3 mice
11:15 11:30 DG-GT05 Ann Christin Franke Hannover Medical School Towards a single-shot prime-boost AAV-based vaccine for cancer immunotherapy
11:30 11:45 BREAK
Session 3 - Safety
CHAIR: Boris Fehse
11:45 12:00 DG-GT06 David Glow University Medical Center Hamburg LATE – a novel sensitive cell-based assay for the study of CRISPR-Cas9 related Long-term adverse Treatment Effects
12:00 12:15 DG-GT07 Julia Klermund University of Freiburg CAST-Seq discloses low frequency of chromosomal rearrangements in double-nickase based genome editing in primary human cells
12:15 12:30 DG-GT08 Antonella Bastone Hannover Medical School Development of a new all-in-one in vitro safety assay for gene therapy to detect lymphoid and myeloid insertional mutants
12:35 13:30 AGM